Ozempic Linked to Significant Reduction in Dementia—Study

newsweek.com/ozempic-linked-significant-reduction-dementiastudy-2090817

Voice is AI-generated. Inconsistencies may occur.
Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced risk of developing Alzheimer's disease-related dementia among patients with type 2 diabetes, a recent study…

This story appeared on newsweek.com, 2025-06-25 22:52:29.
The Entire Business World on a Single Page. Free to Use →